Mohammed Jameez Ummer, Thomas Dixon, Baker Danial
College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.
College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, USA.
J Pharm Bioallied Sci. 2024 Apr-Jun;16(2):79-85. doi: 10.4103/jpbs.jpbs_1025_23. Epub 2024 Jul 15.
Hypertension can lead to cardiovascular and other health complications. Many hypertensive patients in the community may receive poor care and monitoring due to financial and other concerns. Pharmacists could support patients in improving their health outcomes. This research aims to assess the impact of pharmacist-led hypertensive clinics in a community pharmacy setting.
The study was an interventional exploratory design in a community pharmacy in Dubai, UAE. All eligible patients who consented were enrolled in the study, making it a population-based study. Patients' blood pressure (BP) was measured before starting the intervention and measured monthly for a minimum of 6 months of care. Measuring BP, physician referral for management of hypertension, lifestyle, diet, and medication counseling were the interventions provided by the researcher on a case-to-case basis as needed in each patient encounter. Toward the end of the study, a patient satisfaction survey was conducted. The survey form showed internal consistency, Cronbach's alpha = 0.895.
About 30 patients were provided pharmacy services by a pharmacist for 613 months. All patients'' BP were monitored monthly. Patients showed reductions in their systolic and diastolic BP levels with the continued care of the pharmacist. (The mean systolic BP significantly decreased from 155 mmHg (standard deviation (SD) = 14.4, median = 151) at baseline to 128 mmHg (SD = 3.1, median = 129) with a 0.001. The mean diastolic BP showed a decrease from 95 mmHg (SD = 8.4, Median = 93) at baseline to 82 mmHg (SD = 1.2, Median = 81) with a 0.17. The participants showed a high level of patient satisfaction. Some were willing to pay for the pharmacist's professional service.
In conclusion, the study has shown the impact of pharmacist-led antihypertensive clinics in systolic BP control and achieving high patient satisfaction. The study generated insights into participant cooperation with pharmacist services and needs. More research on different outcomes is planned for future studies, including systematic pharmacotherapy work-up, patient medication adherence, and other clinical outcomes in the study population.
高血压可导致心血管及其他健康并发症。由于经济和其他方面的担忧，社区中的许多高血压患者可能接受的护理和监测较差。药剂师可以帮助患者改善健康状况。本研究旨在评估社区药房中由药剂师主导的高血压诊所的影响。
该研究是在阿联酋迪拜的一家社区药房进行的干预性探索性设计。所有符合条件且同意参与的患者均被纳入研究，使其成为一项基于人群的研究。在开始干预前测量患者的血压（BP），并在至少6个月的护理期间每月测量一次。测量血压、将高血压患者转诊给医生进行管理、提供生活方式、饮食和用药咨询是研究人员在每次患者就诊时根据需要逐案提供的干预措施。在研究结束时，进行了患者满意度调查。调查问卷显示出内部一致性，Cronbach's alpha = 0.895。
约30名患者由一名药剂师提供了613个月的药房服务。所有患者的血压每月进行监测。在药剂师的持续护理下，患者的收缩压和舒张压水平均有所降低。（平均收缩压从基线时的155 mmHg（标准差（SD）= 14.4，中位数 = 151）显著降至128 mmHg（SD = 3.1，中位数 = 129），P < 0.001。平均舒张压从基线时的95 mmHg（SD = 8.4，中位数 = 93）降至82 mmHg（SD = 1.2，中位数 = 81），P < 0.17。参与者表现出较高的患者满意度。一些人愿意为药剂师的专业服务付费。
总之，该研究显示了由药剂师主导的抗高血压诊所对收缩压控制和实现高患者满意度的影响。该研究深入了解了参与者与药剂师服务的合作情况及需求。计划在未来的研究中对不同结果进行更多研究，包括系统的药物治疗检查、患者的用药依从性以及研究人群中的其他临床结果。
